|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Portfolio company investments, at fair value: | |||||||||||||||||
| Non-controlled, non-affiliated Investments | |||||||||||||||||
| Non-controlled, affiliated Investments | |||||||||||||||||
| Controlled, affiliated Investments | |||||||||||||||||
| Total portfolio company investments, at fair value | |||||||||||||||||
| Short-term investments (amortized cost of $48,683 and $12,802) | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Receivable for principal payments on investments | |||||||||||||||||
| Investments in money market funds (amortized cost of $22,261 and $25,409) | |||||||||||||||||
| Cash | |||||||||||||||||
| Deposits for investments | |||||||||||||||||
| Receivable for sales of investments | |||||||||||||||||
| Receivable for principal payments on investments | |||||||||||||||||
| Interest receivable | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Total Assets | |||||||||||||||||
| Liabilities: | |||||||||||||||||
| Corporate Credit Facility (Note 6) | |||||||||||||||||
| Unamortized Subscription Credit Facility issuance costs | |||||||||||||||||
| Unamortized Corporate Credit Facility issuance costs | |||||||||||||||||
| Revolving Funding Facility (Note 6) | |||||||||||||||||
| Unamortized Revolving Funding Facility issuance costs | |||||||||||||||||
| Revolving Funding Facility II (Note 6) | |||||||||||||||||
| Unamortized Revolving Funding Facility II issuance costs | |||||||||||||||||
| Subscription Credit Agreement (Note 6) | |||||||||||||||||
| Notes (Note 6) | |||||||||||||||||
| Unamortized notes issuance costs | |||||||||||||||||
| Payable for investments purchased | |||||||||||||||||
| Capital payable (Note 11) | |||||||||||||||||
| Shares repurchased payable (Note 7) | |||||||||||||||||
| Distributions payable | |||||||||||||||||
| Management fee payable (Note 3) | |||||||||||||||||
| Incentive fee payable (Note 3) | |||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||
| Accrued excise tax expense | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Net Assets: | |||||||||||||||||
| Common Shares, $0.001 par value; 100,000,000 shares authorized; 66,216,562 and 65,950,801 as of September 30, 2026 and December 31, 2025 respectively, issued and outstanding | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Total distributable earnings (deficit) | |||||||||||||||||
| Total Net Assets | |||||||||||||||||
| Total Liabilities and Net Assets | |||||||||||||||||
| Net Asset Value Per Common Share (in Dollars per share) | |||||||||||||||||
Loading...